OBJECTIVES: Current clinical algorithms position surgery as the last option in pediatric Crohn disease (CD). Studies suggest improved outcomes with earlier surgery, but pediatric postoperative outcomes data in the biologic era are limited. We aimed to describe the preoperative management and postoperative outcomes in a pediatric CD cohort who underwent ileocolic resection (ICR) at a tertiary care inflammatory bowel disease center over the last decade. METHODS: Single-center, retrospective study of pediatric (<18 years) CD patients who underwent ICR between 2008 and 2019 with primary outcome of rate of endoscopic recurrence (Rutgeerts' >i2) at 2 years post-ICR. Key secondary outcomes included endoscopic remission (Rutgeerts' i0), frequency of 30-day postoperative complications, anthropometric changes, and histologic recurrence. Uni- and multivariable analyses examined associations of clinical/laboratory characteristics with endoscopic recurrence. Factors predictive of 30-day complications were also analyzed. RESULTS: Seventy-eight children underwent ICR a median of 17.8 months (interquartile range [IQR] 2.6-53.9) from diagnosis. Median age at diagnosis and surgery was 13.8 (11.1-16.7) and 16.8 years (15.1-17.8), respectively. In the 41 patients with >1 post-operative endoscopy, the rate of endoscopic recurrence was 46% at 2 years (median time to recurrence: 10 [7-20] months). Histologic recurrence was present in 44% in endoscopic remission (κ = 0.11, P = 0.53). Endoscopic recurrence was associated with younger age at diagnosis and longer disease duration. 30-day complications occurred at a rate of 18%; only 1% experienced severe complications. All anthropometric measures significantly improved after surgery. CONCLUSIONS: Given the inherent risk of postoperative recurrence associated with age and disease duration, children would benefit from postoperative surveillance and effective prophylaxis.
OBJECTIVES: Current clinical algorithms position surgery as the last option in pediatric Crohn disease (CD). Studies suggest improved outcomes with earlier surgery, but pediatric postoperative outcomes data in the biologic era are limited. We aimed to describe the preoperative management and postoperative outcomes in a pediatric CD cohort who underwent ileocolic resection (ICR) at a tertiary care inflammatory bowel disease center over the last decade. METHODS: Single-center, retrospective study of pediatric (<18 years) CD patients who underwent ICR between 2008 and 2019 with primary outcome of rate of endoscopic recurrence (Rutgeerts' >i2) at 2 years post-ICR. Key secondary outcomes included endoscopic remission (Rutgeerts' i0), frequency of 30-day postoperative complications, anthropometric changes, and histologic recurrence. Uni- and multivariable analyses examined associations of clinical/laboratory characteristics with endoscopic recurrence. Factors predictive of 30-day complications were also analyzed. RESULTS: Seventy-eight children underwent ICR a median of 17.8 months (interquartile range [IQR] 2.6-53.9) from diagnosis. Median age at diagnosis and surgery was 13.8 (11.1-16.7) and 16.8 years (15.1-17.8), respectively. In the 41 patients with >1 post-operative endoscopy, the rate of endoscopic recurrence was 46% at 2 years (median time to recurrence: 10 [7-20] months). Histologic recurrence was present in 44% in endoscopic remission (κ = 0.11, P = 0.53). Endoscopic recurrence was associated with younger age at diagnosis and longer disease duration. 30-day complications occurred at a rate of 18%; only 1% experienced severe complications. All anthropometric measures significantly improved after surgery. CONCLUSIONS: Given the inherent risk of postoperative recurrence associated with age and disease duration, children would benefit from postoperative surveillance and effective prophylaxis.
Authors: Alexandra D Frolkis; Jonathan Dykeman; María E Negrón; Jennifer Debruyn; Nathalie Jette; Kirsten M Fiest; Talia Frolkis; Herman W Barkema; Kevin P Rioux; Remo Panaccione; Subrata Ghosh; Samuel Wiebe; Gilaad G Kaplan Journal: Gastroenterology Date: 2013-07-27 Impact factor: 22.682
Authors: James J Ashton; Florina Borca; Enrico Mossotto; Tracy Coelho; Akshay Batra; Nadeem A Afzal; Hang T T Phan; Michael Stanton; Sarah Ennis; Robert Mark Beattie Journal: Aliment Pharmacol Ther Date: 2019-01-09 Impact factor: 8.171
Authors: Judy B Splawski; Marian D Pffefferkorn; Marc E Schaefer; Andrew S Day; Oliver S Soldes; Todd A Ponsky; Philip Stein; Jess L Kaplan; Shehzad A Saeed Journal: J Pediatr Gastroenterol Nutr Date: 2017-10 Impact factor: 2.839
Authors: R N Baldassano; P D Han; W C Jeshion; J A Berlin; D A Piccoli; E Lautenbach; R Mick; G R Lichtenstein Journal: Am J Gastroenterol Date: 2001-07 Impact factor: 10.864
Authors: Britt Christensen; Jonathan Erlich; Peter R Gibson; Jerrold R Turner; John Hart; David T Rubin Journal: Clin Gastroenterol Hepatol Date: 2019-12-05 Impact factor: 11.382
Authors: Peter De Cruz; Michael A Kamm; Amy L Hamilton; Kathryn J Ritchie; Efrosinia O Krejany; Alexandra Gorelik; Danny Liew; Lani Prideaux; Ian C Lawrance; Jane M Andrews; Peter A Bampton; Peter R Gibson; Miles Sparrow; Rupert W Leong; Timothy H Florin; Richard B Gearry; Graham Radford-Smith; Finlay A Macrae; Henry Debinski; Warwick Selby; Ian Kronborg; Michael J Johnston; Rodney Woods; P Ross Elliott; Sally J Bell; Steven J Brown; William R Connell; Paul V Desmond Journal: Lancet Date: 2014-12-24 Impact factor: 79.321
Authors: Karolina Poredska; Lumir Kunovsky; Filip Marek; Zdenek Kala; Vladimir Prochazka; Jiri Dolina; Vladimir Zboril; Petra Kovalcikova; Tomas Pavlik; Petr Jabandziev; Zdenek Pavlovsky; Jakub Vlazny; Ladislav Mitas Journal: J Crohns Colitis Date: 2020-03-13 Impact factor: 9.071